Physician profile
Dargelis Chi
NPI 1053831693
$15,124.54
in general payments reported to CMS, 2019-2025
67 companies · $2,960 in 2025
The $2,960 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2021: $194 · 2022: $3,791 · 2023: $3,616 · 2024: $4,085 · 2025: $2,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,661.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,746.79 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Ucb, INC. | $988.34 | 2022-2025 | Briviact, Nayzilam, Zilbrysq |
| Pfizer INC. | $872.22 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $751.46 | 2019-2025 | Ultomiris, Soliris |
| Emd Serono, INC. | $711.52 | 2019-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $710.44 | 2019-2025 | Austedo Xr, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $679.97 | 2022-2025 | |
| Lilly USA, LLC | $587.24 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Biogen, INC. | $477.09 | 2021-2025 | Vumerity, Tysabri, Plegridy |
| Lundbeck LLC | $451.28 | 2022-2025 | Vyepti, Rexulti |
| Neurelis, INC. | $412.11 | 2022-2025 | Valtoco |
| Eisai INC. | $396.76 | 2021-2025 | |
| Argenx US, INC. | $383.42 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Genzyme Corporation | $341.77 | 2019-2023 | |
| Genentech USA, INC. | $311.48 | 2022-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $296.30 | 2022-2025 | Aimovig, Uplizna |
| Neurocrine Biosciences, INC. | $288.77 | 2022-2025 | Ingrezza, Ongentys |
| Ani Pharmaceuticals, INC. | $282.92 | 2023-2025 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $265.62 | 2022-2024 | Wakix |
| Csl Behring | $264.63 | 2022-2025 | Hizentra |
| Janssen Pharmaceuticals, INC | $254.79 | 2022-2023 | Ponvory |
| Scilex Pharmaceuticals INC. | $252.08 | 2023-2025 | Ztlido |
| Octapharma USA, INC. | $228.42 | 2022-2024 | Panzyga |
| Merz Pharmaceuticals, LLC | $227.45 | 2023-2025 | Xeomin, Inbrija |
| Mdd US Operations, LLC | $217.83 | 2022-2025 | Apokyn, Qelbree, Apokyn |
| Tanabe Pharma America, INC. | $211.24 | 2022-2025 | Radicava |
| Amneal Pharmaceuticals LLC | $206.17 | 2021-2024 | Rytary |
| Acadia Pharmaceuticals INC | $198.82 | 2022-2025 | Nuplazid, Daybue |
| Biohaven Pharmaceutical Holding Company LTD. | $164.26 | 2022 | |
| Celgene Corporation | $133.60 | 2022-2024 | Zeposia |
| Jazz Pharmaceuticals INC. | $128.25 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $127.83 | 2022-2024 | Onpattro |
| Abbott Laboratories | $125.12 | 2023 | Infinity |
| Tg Therapeutics, INC. | $124.48 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.23 | 2022-2024 | Hyqvia |
| Sk Life Science, INC. | $100.20 | 2022 | |
| Acorda Therapeutics, INC | $81.89 | 2019-2024 | Inbrija, Ampyra |
| Medtronic, INC. | $80.04 | 2022-2024 | Reveal Linq, Interstim |
| Allergan, INC. | $70.72 | 2022 | |
| Grifols USA, LLC | $55.71 | 2022-2023 | Gamunex-C |
| Impel Pharmaceuticals INC. | $55.36 | 2022-2023 | Trudhesa |
| Avion Pharmaceuticals | $49.48 | 2022-2023 | Dhivy |
| Aprecia Pharmaceuticals, LLC | $48.14 | 2021-2023 | Spritam |
| Sunovion Pharmaceuticals INC. | $48.05 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $45.84 | 2022-2023 | |
| Kyowa Kirin, INC. | $42.45 | 2023-2024 | Nourianz |
| Springworks Therapeutics, INC. | $42.01 | 2024-2025 | Gomekli |
| Supernus Pharmaceuticals, INC. | $40.47 | 2022 | |
| Horizon Therapeutics Plc | $40.24 | 2022-2023 | Uplizna |
| Vanda Pharmaceuticals INC. | $35.58 | 2024 | Ponvory |
| Janssen Biotech, INC. | $28.32 | 2025 | |
| Mallinckrodt Hospital Products INC. | $27.92 | 2024 | Acthar |
| E.R. Squibb & Sons, L.L.C. | $27.38 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.29 | 2023 | |
| Insightec,INC | $24.12 | 2025 | Exablate |
| Catalyst Pharmaceuticals, INC. | $23.56 | 2022 | |
| Axsome Therapeutics, INC. | $21.74 | 2025 | Symbravo |
| Eli Lilly and Company | $21.41 | 2025 | Amyvid, Kisunla |
| Corium, LLC | $21.19 | 2023 | Adlarity |
| Aquestive Therapeutics, INC. | $20.95 | 2022 | |
| Livanova USA, INC. | $20.58 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ultragenyx Pharmaceutical INC. | $20.17 | 2022 | |
| Boston Scientific Corporation | $19.98 | 2023 | |
| C2n Diagnostics, LLC | $17.08 | 2025 | Precivityad2 |
| Alfasigma USA, INC. | $13.44 | 2022 | |
| Sumitomo Pharma America, INC. | $9.76 | 2023 | Aptiom |
| Dynasplint Systems INC. | $6.77 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dargelis Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.